ESSA PHARMA
ESSA is a pharmaceutical company focused on the development of small molecule drugs for the treatment of cancer, with a focus on advanced prostate cancer. ESSA is developing drugs that selectively block the N-terminal domain of the androgen receptor (AR). The AR is required for the growth and survival of most prostate cancer; therefore, the AR N-terminal domain is an ideal target for next-generation hormone therapy.
ESSA PHARMA
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2009-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.essapharma.com
Total Employee:
11+
Status:
Active
Contact:
(832) 831-5958
Email Addresses:
[email protected]
Total Funding:
280.73 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-05-16 | Realm Therapeutics | Realm Therapeutics acquired by ESSA Pharma | N/A |
Investors List
BVF Partners
BVF Partners investment in Post-IPO Equity - ESSA Pharma
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Equity - ESSA Pharma
Pfizer Breakthrough Growth Initiative
Pfizer Breakthrough Growth Initiative investment in Post-IPO Equity - ESSA Pharma
Vivo Capital
Vivo Capital investment in Post-IPO Equity - ESSA Pharma
CAM Capital
CAM Capital investment in Post-IPO Equity - ESSA Pharma
Avidity Partners
Avidity Partners investment in Post-IPO Equity - ESSA Pharma
Ridgeback Capital
Ridgeback Capital investment in Post-IPO Equity - ESSA Pharma
Sphera Global Healthcare Fund
Sphera Global Healthcare Fund investment in Post-IPO Equity - ESSA Pharma
Pfizer
Pfizer investment in Post-IPO Equity - ESSA Pharma
Point72
Point72 investment in Post-IPO Equity - ESSA Pharma
Official Site Inspections
http://www.essapharma.com Semrush global rank: 8.76 M Semrush visits lastest month: 261
- Host name: 37.115.215.35.bc.googleusercontent.com
- IP address: 35.215.115.37
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "ESSA Pharma"
ESSA Pharma - LinkedIn
ESSA is a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer. ESSA’s lead clinical candidate, EPI-7386, represents a new … See details»
ESSA Pharma - Crunchbase Company Profile & Funding
ESSA Pharma is a biotechnology company that develops new drugs for prostate cancer. See details»
ESSA Pharma (EPIX) Company Profile & Description
Jul 9, 2025 Company profile for ESSA Pharma Inc. (EPIX) stock, with a description, list of executives, contact details and other key facts. See details»
ESSA Pharma Inc Company Profile | Management and Employees …
Find contact information for ESSA Pharma Inc. Learn about their Research & Development, Business Services market share, competitors, and ESSA Pharma Inc's email format. See details»
Essa Pharma - Developing the Next Generation of …
ESSA is a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer. ESSA’s lead clinical candidate, masofaniten (formerly EPI-7386), represents a new approach to disrupting the … See details»
ESSA Pharma Inc. Announces Definitive Agreement to be
3 days ago T: 778-331-0962 E: [email protected] or Nick Lamplough / Dan Moore [email protected] XenoTherapeutics Contact Information: Jon Adkins … See details»
ESSA is developing proprietary therapies for prostate …
Essa is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of prostate cancer. Prostate cancer is predominantly driven by the androgen receptor (AR). The current standard of … See details»
ESSA Pharma - Craft
ESSA Pharma has 5 employees across 3 locations. See insights on ESSA Pharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. See details»
ESSA Pharma - Overview, News & Similar companies | ZoomInfo.com
Apr 9, 2024 View ESSA Pharma (www.essapharma.com) location in British Columbia, Canada , revenue, industry and description. Find related and similar companies as well as employees … See details»
ESSA Pharma Inc. - PRISM MarketView
About ESSA Pharma Inc. ESSA is a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer. ESSA’s lead clinical candidate, EPI-7386, represents a new approach to … See details»
ESSA is developing proprietary therapies for prostate cancer …
Essa is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of prostate cancer. See details»
ESSA Pharma Overview | SignalHire Company Profile
The number of employees ranges from 25 to 100. The annual revenue of ESSA Pharma varies between 5.0M and 25M. Total funding of the company - $114M. To connect with ESSA … See details»
Executive Team - Essa Pharma
Dr. Glickman has served as the founding Chairman of the Board of the Company since October 2010 and is one of Canada’s best known and most successful healthcare entrepreneurs. Dr. … See details»
ESSA Pharma Inc. Announces Definitive Agreement to be Acquired …
3 days ago T: 778-331-0962 E: [email protected] or Nick Lamplough / Dan Moore [email protected] XenoTherapeutics Contact Information: Jon Adkins … See details»
Site Map - Essa Pharma
400 Oyster Point Blvd., Suite 520South San Francisco, CA 94080 See details»
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL …
Mar 6, 2025 Contact Information: David Wood Chief Financial Officer, ESSA Pharma Inc. T: 778-331-0962 E: [email protected] About ESSA Pharma Inc. See details»
Essa Pharma Inc. Company Profile | StatInvestor
Essa Pharma Company Profile. Learn more about who Essa Pharma is. Get financial information, who is the owner of Essa Pharma and key facts about Essa Pharma Inc. See details»
Executive Team - Essa Pharma
Merendino also held positions of increasing authority at Genentech in commercial organization across sales, marketing and strategy, with a focus in oncology. Throughout her career, she … See details»
Contact Us - Essa Pharma
British Columbia 999 West Broadway, Suite 720 Vancouver, BC V5Z 1K5 (778) 331-0962 [email protected] See details»
ESSA Pharma CEO and Key Executive Team - Craft.co
ESSA Pharma's Chairman of the Board is Richard Glickman. Other executives include David R. Parkinson, President, Chief Executive Officer & Director; Peter Virsik, Chief Operating Officer, … See details»